Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Applied Molecular Transport Inc. (AMTI : NSDQ)
 
 • Company Description   
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. It design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic and other diseases. The company's lead product candidate consist AMT-101, which is in clinical stage. Applied Molecular Transport Inc. is based in Calif.

Number of Employees: 79

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.27 Daily Weekly Monthly
20 Day Moving Average: 101,189 shares
Shares Outstanding: 39.34 (millions)
Market Capitalization: $10.50 (millions)
Beta: 1.98
52 Week High: $4.17
52 Week Low: $0.21
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.69% -1.20%
12 Week -53.26% -56.62%
Year To Date -36.43% -42.17%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
450 East Jamie Court
-
South San Francisco,CA 94080
USA
ph: 650-392-0420
fax: -
asantos@wheelhouselsa.com http://www.appliedmt.com
 
 • General Corporate Information   
Officers
Tahir Mahmood - Co-Founder; Chief Executive Officer and Director
Brandon Hants - Chief Financial Officer
Charlene Banard - Director
David Lamond - Director
John Smither - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 03824M109
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/23
Next Expected EPS Date: 08/03/23
Share - Related Items
Shares Outstanding: 39.34
Most Recent Split Date: (:1)
Beta: 1.98
Market Capitalization: $10.50 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.23 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.38 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 52.33% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/23  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.29
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 35.45%
vs. Previous Quarter: -22.41%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/23 - -163.54
12/31/22 - -138.50
09/30/22 - -114.57
ROA
03/31/23 - -96.55
12/31/22 - -90.07
09/30/22 - -80.25
Current Ratio
03/31/23 - 2.75
12/31/22 - 4.24
09/30/22 - 5.68
Quick Ratio
03/31/23 - 2.75
12/31/22 - 4.24
09/30/22 - 5.68
Operating Margin
03/31/23 - -
12/31/22 - -
09/30/22 - -
Net Margin
03/31/23 - -
12/31/22 - -
09/30/22 - -
Pre-Tax Margin
03/31/23 - -
12/31/22 - -
09/30/22 - -
Book Value
03/31/23 - 0.92
12/31/22 - 1.56
09/30/22 - 2.02
Inventory Turnover
03/31/23 - -
12/31/22 - -
09/30/22 - -
Debt-to-Equity
03/31/23 - 0.00
12/31/22 - 0.00
09/30/22 - 0.00
Debt-to-Capital
03/31/23 - 0.31
12/31/22 - 0.08
09/30/22 - 0.08
 

Powered by Zacks Investment Research ©